Reduction of decoder convolutional blocks in Attention Gate U-Net++ to enhance computational efficiency in automatic HR-CTV delineation on CT-based cervical cancer brachytherapy images
Journal of Associated Medical Sciences · 27.07.2026 · 59 (3) · 313-324
DOI: 10.66285/jams.2026.104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Associated Medical Sciences, online erschienen am 27.07.2026. Verfasst von Thinnagit Srikhot und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The contour of the high-risk clinical target volume (HR-CTV) is important in computed tomography (CT)-based cervical cancer brachytherapy to ensure adequate target tumor coverage while sparing radiation exposure to organs at risk (OARs). Although Attention U-Net++ has demonstrated improved segmentation performance, its complex decoder structure substantially increases computational cost and training time.
Objectives
This study aimed to develop a computationally efficient modified Attention U-Net++ architecture by reducing decoder depth while preserving segmentation performance for HR-CTV delineation. Materials and methods: A retrospective dataset comprising 3,323 CT images from 56 patients with cervical cancer was analyzed. The proposed model eliminates the deepest decoder level to reduce redundant feature propagation and overall model complexity. Segmentation performance was evaluated using the Dice Similarity Coefficient (DSC), Intersection over Union (IoU), 95th percentile Hausdorff Distance (HD95), Accuracy, Precision, and Recall. Computational efficiency was assessed by the number of trainable parameters, training time, and inference time, and was compared with the baseline Attention U-Net++ architecture and related models.
Results
The proposed Attention U-Net++ DL3 reduced the number of trainable parameters from 37.30 million to 8.86 million and shortened training time from 52.27 minutes to 33.11 minutes, while maintaining a comparable inference time (36.90 seconds). Geometric evaluation demonstrated a DSC of 0.9076 and IoU of 0.8376, marginally outperforming the baseline Attention U-Net++ (DSC 0.9057; IoU 0.8338). The HD95 value was 1.3959, which is comparable to existing architectures. Pixel-level classification performance remained robust, with an accuracy of 0.9996, precision of 0.9046, and recall of 0.9298. Overall, the proposed model achieved competitive segmentation performance with substantially reduced model complexity.
Conclusion
Reducing decoder convolutional blocks in Attention U-Net++ significantly improves computational efficiency while preserving segmentation accuracy. The proposed lightweight architecture provides an optimal balance between performance and resource utilization, supporting its practical implementation in CT-based cervical cancer brachytherapy, particularly in resource-limited clinical settings.
Zitieren
APA
Srikhot, T., Pattaweerakul, C., Nobphuek, K., & Kaewlek, T. (2026). Reduction of decoder convolutional blocks in Attention Gate U-Net++ to enhance computational efficiency in automatic HR-CTV delineation on CT-based cervical cancer brachytherapy images. Journal of Associated Medical Sciences, 59(3), 313-324. https://doi.org/10.66285/jams.2026.104
Vancouver
Srikhot T, Pattaweerakul C, Nobphuek K, Kaewlek T. Reduction of decoder convolutional blocks in Attention Gate U-Net++ to enhance computational efficiency in automatic HR-CTV delineation on CT-based cervical cancer brachytherapy images. Journal of Associated Medical Sciences. 2026;59(3):313-324. doi:10.66285/jams.2026.104
BibTeX
@article{Srikhot2026,
author = {Srikhot, Thinnagit and Pattaweerakul, Chatrawut and Nobphuek, Kamonchanok and Kaewlek, Titipong},
title = {Reduction of decoder convolutional blocks in Attention Gate U-Net++ to enhance computational efficiency in automatic HR-CTV delineation on CT-based cervical cancer brachytherapy images},
journal = {Journal of Associated Medical Sciences},
year = {2026},
volume = {59},
number = {3},
pages = {313--324},
doi = {10.66285/jams.2026.104}
}
EUVIMED